🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction academic.oup.com/eurheartj/adva…

Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction academic.oup.com/eurheartj/adva…

Marta Belmonte Emanuele Gallinoro, MD, PhD Matteo Armillotta Angelo Sansonetti Alberto Foà carmine pizzi

MINOCA? Aortitis? Adrenal hematoma? Can you link all of them? This case report shows Antiphospholipid Syndrome as a "Clinical Chimera" and remarks the importance of multimodality imaging Carmine Pizzi Daniele Cavallo Matteo Armillotta OTAVIO RIZZI COELHO FILHO, MD PhD MPH ahajournals.org/doi/abs/10.116…

Carmine Pizzi Alberto Foà Pasquale Paolisso Matteo Armillotta Angelo Sansonetti Stefano Carugo Michele Fabrizio JACC Journals Università di Bologna

📌 Very happy to share our results at #ESCCongress #ESC2023. 🔥 Prognostic role of early #whyCMR in #MINOCA patients. Proub to be part of this great team: Carmine Pizzi Luca Bergamaschi Alberto Foà Pasquale Paolisso Angelo Sansonetti European Society of Cardiology For more insights 👉 sciencedirect.com/science/articl…

🚨 Predictive value of Killip class 🩺 in MINOCA ➡️ High Killip class is an independent predictor of MACE and death in MINOCA ➡️ High Killip class MINOCA show a higher risk of HF than MIOCA counterparts Explore our latest paper on European Journal of Internal Medicine 👇 sciencedirect.com/science/articl…

Yesterday, one year ago, our beloved friend, Master of Medicine and Cardiology Claudio Rapezzi left. You are always in our mind and in our heart, Claudio.

Proud that our paper on #CMR to predict Cardiac Masses Malignancy is in the 🚀top 6 most read articles of 2024 so far in #CirculationCardiovascularImaging ahajournals.org/doi/10.1161/CI… #TheCMRMassScore🧲🫀

Marco Guglielmo MD, FEACVI, FSCCT Luca Bergamaschi Carmine Pizzi @damiano Gianluca Pontone Great things are coming for #whyCMR ❤️

Cardiac mass are always a challenge! 27yo F with apical cardiac mass, stabile in years Benign nature according to Bologna CMR mass score: pubmed.ncbi.nlm.nih.gov/38502734/ #whyCMR Any clues on what it is? Alexandros Kallifatidis Manish Motwani Anna Baritussio Luca Bergamaschi Pasquale Paolisso C Bucciarelli-Ducci

🔥In HTx recipients, FAI was an independent predictor of MACEs and allograft rejection. 🎯FAI assessment could be part of CCTA analysis in routine surveillance of HTx recipients! Read more of our group's simultaneous publication during #ESCCongress2024 in JACC Journals #JACCIMG

In HTx recipients, FAI was an independent predictor of MACEs and allograft rejection. FAI assessment could be part of CCTA analysis in routine surveillance of HTx recipients, potentially improving pts' care. bit.ly/4g81p2X #JACCIMG #ESCCongress Angelo Sansonetti

"Hepatic T1 mapping has emerged as a novel imaging biomarker of the cardio-hepatic axis in STEMI, being associated with RV involvement and increased NT-proBNP" doi.org/10.1093/ehjci/… Thanks to Anna Giulia Pavon for the leadership and to the whole Team! #whyCMR #CVimaging

~~ Cardiac Masses ~~ Benign vs malignant on multimodality imaging #EchoFirst #yesCCTA #whycmr

Cardiac masses often represent a challenge for clinicians, particularly in terms of Dx. Multimodality #cvImaging now offers a unique opportunity to cost-effectively improve the Dx, mgmt, & potentially outcomes of pts w/ cardiac masses. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CMR

For heart transplant (HTx) patients, CCTA might be considered the preferred imaging modality for annual surveillance of CAV after the first year post-HTx Marta Belmonte Pasquale Paolisso Luca Bergamaschi Hirofumi Ohashi Emanuele Gallinoro, MD, PhD Angelo Sansonetti Carmine Pizzi ahajrnls.org/4h3GzRR

Non-invasive vs. Invasive Approach to Cardiac Allograft Vasculopathy Surveillance: The Role of Coronary CT Angiography (CCTA-HTx Study) 👉 is now out on CircImaging ! Our main findings were: 🔥The combination of CCTA-derived coronary DS (DS>35%) and plaque morphology (plaque

🇮🇹 pubmed.ncbi.nlm.nih.gov/39505122/

💊SGLT2i pleiotropic effects have demonstrated efficacy across various cardiovascular conditions, ranging from acute to chronic coronary syndromes and extending to arrhythmias, valvular heart disease, cardiomyopathies, cardio-oncology, and cerebrovascular disease! 🔍Our review